Project Details
Description
Randomized double-blind placebo-controlled trial Evaluating baricitinib on persistent neurologic and cardiopulmonary symptoms of Long COVID (REVERSE-LC) Study
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/24 → 12/31/24 |
Funding
- VANDERBILT UNIVERSITY MEDICAL CENTER
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.